Raymond James SEC Filings

Raymond James Financial, Inc. disclosed a material event reporting the execution of a Second Amended and Restated Credit Agreement dated September 23, 2025. The agreement parties listed in the filing are Raymond James Financial, Inc., Raymond James & Associates, Inc., the lenders party thereto and Bank of America, N.A. The filing includes a cover page interactive data file and is signed by Jonathan W. Oorlog, Jr., Chief Financial Officer.

Raymond James Financial, Inc. disclosed documentation related to a securities transaction and supporting exhibits. The filing lists depositary shares representing a 1/40th interest in a share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock and an Underwriting Agreement dated September 9, 2025. It references the original Indenture dated August 10, 2009, and Tenth and Eleventh Supplemental Indentures dated September 11, 2025. Forms of 4.900% Senior Notes due 2035 and 5.650% Senior Notes due 2055 are included as exhibits, together with legal opinions and consents, a September 9, 2025 press release, and embedded interactive cover page data. The filing is signed by CFO Jonathan W. Oorlog, Jr.

Haynes Morgan Tarazeta J, Chief Audit Executive of Raymond James Financial (RJF), reported a gift of 114 shares of Raymond James common stock executed on 08/18/2025 (transaction code G) at a reported price of $0.0000. After the transaction the reporting person beneficially owned 3,631 shares directly and 376 shares indirectly through an ESOP account, with the filing noting the ESOP holdings include shares through August 18, 2025. The Form 4 was signed by an attorney-in-fact.

Raymond James Financial, Inc. prospectus supplement for debt securities contains standard offering disclosures, key covenants and investor risk notices. The indenture expressly does not limit the company or its subsidiaries from incurring additional debt, and holders’ remedies are curtailed by a 30-day cure period that applies to interest nonpayment but not to principal or premium, which may delay acceleration rights. The document highlights settlement and market mechanics, including same-day funds settlement for certain notes and the marketwide move to shorter trade settlement cycles (T+1 effective May 28, 2024).

The prospectus explains currency and tax risks for Non-U.S. Dollar-Denominated Securities: depreciation, convertibility limits, governmental controls, and conversion/settlement mechanics may reduce U.S. dollar-equivalent payments. It also details ERISA and Non-ERISA purchaser representations, tax certification requirements for reduced withholding, DTC and book-entry mechanics, and includes unaudited balance-sheet line items as of June 30, 2025 (selected figures shown in the supplement).

Raymond James Financial, Inc. reported a material event in an 8-K dated August 20, 2025 announcing that its Board declared a quarterly cash dividend of $0.3984375 per depositary share on its 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock (NYSE: RJF PrB). The dividend is payable October 1, 2025 to holders of record on September 15, 2025. The press release announcing the declaration is furnished as Exhibit 99.1 and is incorporated by reference into the report. The filing notes the exhibit is being "furnished" and not "filed" for purposes of Section 18 of the Exchange Act.

Raymond James Financial Inc. filed a Form 13F-HR reporting its U.S. Section 13(f) equity holdings as of 06-30-2025. The report lists 15,750 information table entries with a total market value of $290,499,498,174. The filing identifies 13 other included managers (subsidiaries and related advisers) by name and Form 13F file number. The signatory is Rachel Jacobson, Manager, Operations, signing on behalf of the reporting manager. The filing notes a change in reporting approach beginning with the quarter ending December 31, 2024: the Reporting Person now uses Form 13F-HR to report positions held by subsidiaries, while subsidiaries with >$100 million under management will file Form 13F-NT and designate the Reporting Person as Other Manager Reporting.

This Form 4 discloses insider activity by Jonathan N. Santelli, identified as Executive Vice President, General Counsel and Secretary of Raymond James Financial, Inc. (RJF). The filing reports a gift transaction dated 08/12/2025 in which 300 shares of RJF common stock were transferred (transaction code G). After the reported transaction, the reporting person beneficially owned 22,579 shares directly. The filing also shows 539 shares held indirectly in an ESOP account, with the explanatory note stating those ESOP shares are included through August 12, 2025. The form is signed by an attorney-in-fact on behalf of Mr. Santelli on 08/14/2025.

The document is a routine Section 16 disclosure showing a non-derivative transfer by gift and the continued beneficial ownership breakdown between direct holdings and an ESOP account. No option grants, exercises, sales, or derivative transactions are reported on this form.